New venture aligns with Jaguar’s mental health Entheogen Therapeutics Initiative (ETI) and Filament’s corporate mission to develop novel, natural prescription medicines from plants Magdalena Biosciences will leverage Jaguar’s proprietary medicinal plant library and Filament’s proprietary drug development technology Magdalena Biosciences is currently valued at US$5.0 million based on initial and…

Source

Previous articlePsychedelic Research Bulletin: December 2022
Next articleatai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917